Dr Waiter wrote in a memo that in order to meet the anticipated demand for the principal plasma fractions, a new plant would have to be acquired. Plans for the future development of BPL had by this time been drawn up.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Self-Sufficiency
Key Person(s)
Dr Sheila Waiter